Capital International’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.62M	Sell	29,078 -38,589	-57%	-$13.1M	0.36%	78
2025 Q4	$26.9M	Sell	67,667 -10,556	-13%	-$4.67M	0.95%	30
2025 Q3	$35.7M	Sell	78,223 -4,577	-6%	-$1.86M	1.29%	18
2025 Q2	$27M	Buy	82,800 +894	+1%	+$247K	1.03%	25
2025 Q1	$22.1M	Buy	81,906 +1,624	+2%	+$417K	0.96%	31
2024 Q4	$18.9M	Sell	80,282 -20,141	-20%	-$5.3M	0.77%	35
2024 Q3	$27.6M	Buy	100,423 +6,198	+7%	+$1.61M	1.19%	23
2024 Q2	$22.9M	Buy	94,225 +29,001	+44%	+$4.58M	1.06%	25
2024 Q1	$9.75M	Sell	65,224 -23,161	-26%	-$3.86M	0.47%	69
2023 Q4	$16.9M	Sell	88,385 -4,571	-5%	-$779K	0.87%	32
2023 Q3	$16.5M	Sell	92,956 -625	-0.7%	-$119K	0.95%	28
2023 Q2	$17.8M	Hold	93,581	–	–	1%	25
2023 Q1	$18.7M	Buy	93,581 +5,536	+6%	+$1.16M	1.12%	21
2022 Q4	$20.9M	Buy	88,045 +20,030	+29%	+$4.27M	1.44%	12
2022 Q3	$13.6M	Buy	68,015 +22,023	+48%	+$4.2M	0.95%	27
2022 Q2	$6.71M	Buy	45,992 +24,153	+111%	+$3.43M	0.5%	64
2022 Q1	$3.57M	Buy	+21,839	New	+$3.33M	0.2%	110